Related Experiment Video
Updated: Jul 12, 2025

10:05
Single-cell Transcriptomic Analyses of Mouse Pancreatic Endocrine Cells
Published on: September 30, 2018
11.1K
Single-Cell Transcriptome Profiling of Pancreatic Islets From Early Diabetic Mice Identifies Anxa10 for Ca2+
Kaori Motomura1,2, Takashi Matsuzaka1,3, Shigeyuki Shichino2
1Department of Endocrinology and Metabolism, Institute of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Diabetes
|October 23, 2023
Summary
Researchers identified a new gene, Anxa10, involved in type 2 diabetes progression. This gene impacts calcium regulation and insulin secretion in beta cells, contributing to diabetes development.
Area of Science:
- Endocrinology
- Molecular Biology
- Genetics
Background:
- Type 2 diabetes is characterized by hyperglycemia and declining beta-cell function.
- The precise mechanisms driving beta-cell failure in diabetes remain incompletely understood.
Purpose of the Study:
- To investigate the single-cell transcriptome landscape of pancreatic islets in prediabetic and diabetic mouse models.
- To identify novel genes and cellular processes contributing to beta-cell dysfunction and diabetes progression.
Main Methods:
- Single-cell RNA sequencing of pancreatic islets from db/db mice (a model for type 2 diabetes).
- Analysis of gene expression, cell subpopulations, and cellular trajectories using pseudotime analysis.
Main Results:
- A distinct transcriptome landscape was observed in diabetic islet cells, including specific beta- and alpha-cell subpopulations.
- A novel prediabetic gene, Anxa10, was identified, regulating calcium influx and suppressing insulin secretion in beta cells.
- Pseudotime analysis indicated that Anxa10-expressing beta cells progress towards mitochondrial dysfunction and endoplasmic reticulum stress.
- Evidence of beta-cell dedifferentiation and transdifferentiation into acinar-like cells was found in diabetic islets.
Conclusions:
- The study provides novel insights into calcium allostasis and beta-cell failure mechanisms in type 2 diabetes.
- Anxa10 emerges as a key regulator of beta-cell function and a potential therapeutic target.
- Cellular plasticity, including transdifferentiation, plays a significant role in diabetes pathogenesis.

